Previous Close | 30.47 |
Open | 31.90 |
Bid | 30.90 |
Ask | 31.80 |
Strike | 40.00 |
Expire Date | 2024-07-19 |
Day's Range | 30.84 - 31.90 |
Contract Range | N/A |
Volume | |
Open Interest | 6 |
Changes in MMSE after treatment with 10mg or 20mg buntanetap compared to baseline and placebo Figure 1. Changes in MDS-UPDRS after treatment with 10mg or 20mg buntanetap in patients with a PD diagnosis over 3 years compared to baseline and placebo Figure 2. Changes in MDS-UPDRS after treatment with 10mg or 20mg buntanetap in patients with PIGD Figure 3. Buntanetap showed dose-dependent and statistically significant improvements in cognition in the overall enrolled PD population. Parkinson’s pati
Merck's (MRK) vaccine, Capvaxive, gets unanimous recommendation by a CDC committee for adults aged 65 years and older for pneumococcal vaccination and those with certain other underlying conditions.
CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.